Long-term smoking cessation: from general practice to public health

Long-term smoking cessation: from general practice to public health International Journal of Epidemiology, 2018, 1 doi: 10.1093/ije/dyy083 Letter to the Editor Letter to the Editor Long-term smoking cessation: from general practice to public health Alain Braillon Department of Medicine, University Hospital, 80000, Amiens, France. E-mail: braillon.alain@gmail.com Taylor et al. must be commended for their observational rarely implemented. It allows the patient to easily implement study in the general practice setting, showing that long- the dose–response principle and to cope with craving. term smoking cessation was more frequent with vareni- Third, could Taylor et al. provide data about motiva- cline than with nicotine replacement therapy (NRT): 29% tional interviewing and psychological support? Cigarette vs 24% at 2 years (odds ratio, 1.3). Indeed, too few data smoking is one of the worst addictions and most smokers are available in the real-life setting, as well as in the long have experienced several painful and desperate failures. term. However, this work warranted some comments. They need to be cared for with reassurance, information First, the Clinical Practice Research Datalink, a provision and motivation. Psychological support is a key 3,4 not-for-profit research service funded by the NHS National issue for smoking cessation. Institute for Health Research and the Medicines and References Healthcare products Regulatory Agency, is a most unique achievement. Accordingly, participating practitioners may 1. Taylor GMJ, Taylor AE, Thomas KH et al. The effectiveness of be among the best professionals, even more so as they varenicline versus nicotine replacement therapy on long-term receive regular practice-level prescribing and patient safety smoking cessation in primary care: a prospective cohort study of electronic medical records. Int J Epidemiol 2017;46:1948–57. reports, including patient case-finding and national practice 2. Stead LF, Perera R, Bullen C et al. Nicotine replacement therapy benchmarking. This could explain the high rate of smoking for smoking cessation. Cochrane Database Syst Rev 2012;11: cessation recorded. Could Taylor et al. provide the percent- CD000146. age of general practitioners in England participating in the 3. Leas EC, Pierce JP, Benmarhnia T et al. Effectiveness of pharma- Datalink? ceutical smoking cessation aids in a nationally representative Second, only 23% of the patients prescribed NRT were cohort of American smokers. J Natl Cancer Inst 2017, Dec 21. prescribed more than one nicotine product. This could ex- doi: 10.1093/jnci/djx240. plain the difference compared with varenicline: the ‘belt and 4. Apollonio D, Glantz SA. Tobacco industry research on nicotine replacement therapy: “If anyone is going to take away our busi- braces’ strategy (patches combined with faster acting forms— ness it should be us”. Am J Public Health 2017;107:1636–42. lozenge or spray) doubles the odds ratio of quitting but is too V The Author(s) 2018; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 1 Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy083/4993476 by Ed 'DeepDyve' Gillespie user on 12 July 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Epidemiology Oxford University Press

Long-term smoking cessation: from general practice to public health

Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/long-term-smoking-cessation-from-general-practice-to-public-health-mW6NcATgY6
Publisher
Oxford University Press
Copyright
© The Author(s) 2018; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association
ISSN
0300-5771
eISSN
1464-3685
D.O.I.
10.1093/ije/dyy083
Publisher site
See Article on Publisher Site

Abstract

International Journal of Epidemiology, 2018, 1 doi: 10.1093/ije/dyy083 Letter to the Editor Letter to the Editor Long-term smoking cessation: from general practice to public health Alain Braillon Department of Medicine, University Hospital, 80000, Amiens, France. E-mail: braillon.alain@gmail.com Taylor et al. must be commended for their observational rarely implemented. It allows the patient to easily implement study in the general practice setting, showing that long- the dose–response principle and to cope with craving. term smoking cessation was more frequent with vareni- Third, could Taylor et al. provide data about motiva- cline than with nicotine replacement therapy (NRT): 29% tional interviewing and psychological support? Cigarette vs 24% at 2 years (odds ratio, 1.3). Indeed, too few data smoking is one of the worst addictions and most smokers are available in the real-life setting, as well as in the long have experienced several painful and desperate failures. term. However, this work warranted some comments. They need to be cared for with reassurance, information First, the Clinical Practice Research Datalink, a provision and motivation. Psychological support is a key 3,4 not-for-profit research service funded by the NHS National issue for smoking cessation. Institute for Health Research and the Medicines and References Healthcare products Regulatory Agency, is a most unique achievement. Accordingly, participating practitioners may 1. Taylor GMJ, Taylor AE, Thomas KH et al. The effectiveness of be among the best professionals, even more so as they varenicline versus nicotine replacement therapy on long-term receive regular practice-level prescribing and patient safety smoking cessation in primary care: a prospective cohort study of electronic medical records. Int J Epidemiol 2017;46:1948–57. reports, including patient case-finding and national practice 2. Stead LF, Perera R, Bullen C et al. Nicotine replacement therapy benchmarking. This could explain the high rate of smoking for smoking cessation. Cochrane Database Syst Rev 2012;11: cessation recorded. Could Taylor et al. provide the percent- CD000146. age of general practitioners in England participating in the 3. Leas EC, Pierce JP, Benmarhnia T et al. Effectiveness of pharma- Datalink? ceutical smoking cessation aids in a nationally representative Second, only 23% of the patients prescribed NRT were cohort of American smokers. J Natl Cancer Inst 2017, Dec 21. prescribed more than one nicotine product. This could ex- doi: 10.1093/jnci/djx240. plain the difference compared with varenicline: the ‘belt and 4. Apollonio D, Glantz SA. Tobacco industry research on nicotine replacement therapy: “If anyone is going to take away our busi- braces’ strategy (patches combined with faster acting forms— ness it should be us”. Am J Public Health 2017;107:1636–42. lozenge or spray) doubles the odds ratio of quitting but is too V The Author(s) 2018; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 1 Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy083/4993476 by Ed 'DeepDyve' Gillespie user on 12 July 2018

Journal

International Journal of EpidemiologyOxford University Press

Published: May 7, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off